Opinion

Human cells
#Biobridge Global #Blood Centers of America #CAR-TCR Summit #Terumo Blood And Cell Technologies #TrakCel

CAR-TCR 2023: Key event takeaways 

The 8th CAR-TCR Summit returned to Boston from 29 August to 1 September 2023, bringing together key updates on CARs, TCRs and a variety of cell types. DDW’s Megan Thomas heard from attendees about their key takeaways from the event.  Dr Mindy Miller, Lead Research Scientist,… Read More

#Exclusive Content #Opinion

#Ageing #Cancer research #Epigenetics #Gene regulation #HKG Epitherapeutics #Precision medicine

The epigenetic edge: Harnessing precision medicine’s potential 

HKG Epitherapeutics is a biotechnology company developing novel tools for the early detection of cancer and promoting healthy aging. Founder Dr Moshe Szyf Founder shares the potential of harnessing precision medicine.  Embarking on a new era of medicine  The advent of genomics has ushered in… Read More

#Business & Investment #Exclusive Content #Opinion

Advanced therapies
#Advanced Therapies #CAR-T #Cell and gene therapy #Drug development

Commercialising advanced therapies: Industry perspectives 

Dr Christian K Schneider, Head of Biopharma Excellence at PharmaLex, presents the findings of an industry panel debate on barriers to commercialisation of novel treatments, and the most effective strategies to bring them to market.  With so many exciting novel treatments emerging from the labs, biotechs and pharma companies… Read More

#Exclusive Content #Opinion

Decentralisation and the future of clinical trials  

Paul O’Donohoe, Senior Director, eCOA Product and Science at Medidata, looks at the potential of decentralised clinical trials following the Covid-19 pandemic and how the industry will be affected going forward.   The role that Covid-19 played in advancing decentralised clinical trials (DCTs) cannot be underestimated. Many people, however, wrongly… Read More

#Exclusive Content #Opinion

#Ariceum Therapeutics #Cancer research #Meet the Researcher #Radiopharmaceuticals

Meet the researcher: Germo Gericke, Ariceum Therapeutics

Germo Gericke, Ariceum Therapeutics, tells DDW’s Megan Thomas about his work in radiopharmaceuticals for the treatment of cancer and offers valuable advice to others in this field. 1. Where do you work, and can you tell us what you’re working on at the moment? I am the Chief Medical Officer… Read More

#Cancer Research #Exclusive Content #Opinion

Cancer immuno-oncology
#AI / data analytics / healthtech / informatics #Bispecific Antibodies #Bispecific therapeutics #Cambridge Healthtech Institute #Cancer immunotherapy #Events #Immuno-oncology #Next generation sequencing

Immuno-Oncology Summit Europe 2023: Programme highlights 

From June 20-22, 2023, Cambridge Healthtech Institute hosted the seventh annual Immuno-Oncology Summit Europe in London. DDW’s Megan Thomas shares highlights from the event programmes.   Programmes   This year’s summit was made up of conference programmes, which included: Modulating the Tumour Microenvironment; Next-Generation Cell-Based Immunotherapies; Bispecific… Read More

#Cancer Research #Exclusive Content #Opinion

Cancer cell
#AACR 2023 #Cancer research #DDW Events podcast #Meet the Researcher #Oncology #Surface Oncology

Meet the Researcher: Vito Palombella, Surface Oncology 

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. Thomas speaks with Vito Palombella, Chief Scientific Officer at Surface Oncology.  MT: Where do… Read More

#Cancer Research #Exclusive Content #Opinion

#AACR 2023 #Cancer research #DDW Events podcast #Meet the Researcher #Oncology #Surface Oncology

Don’t miss AACR 2023 on the DDW Events podcast 

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, which took place in April 2023, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research, who you will hear from across three episodes of the… Read More

#Cancer Research #News #Opinion

Cancer cells
#AACR 2023 #Cancer research #CAR-T #DDW Events podcast #Meet the Researcher #T cell receptor (TCR) #Triumvira Immunologics

Meet the Researcher: Andreas Bader, Triumvira Immunologics

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. Thomas speaks with Andreas Bader, Chief Scientific Officer at Triumvira Immunologics. MT: Where do… Read More

#Cancer Research #Exclusive Content #Opinion

Cancer cells
#AACR 2023 #Cancer research #DDW Events podcast #Kintara Therapeutics #Meet the Researcher #Therapeutics

Meet the Researcher: Dennis Brown, Kintara Therapeutics 

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. Thomas speaks with Dennis Brown, Chief Scientific Officer at Kintara Therapeutics. You can also listen to… Read More

#Cancer Research #Exclusive Content #Opinion

#AACR #AACR 2023 #Cancer #Cancer research #Comment #Events

Reflections from AACR 2023

DDW’s Megan Thomas provides highlights from AACR 2023, the American Association of Cancer Research’s annual meeting from 14-19 April 2023 in Orlando, Florida, US.  Meet the incoming AACR President  Having said goodbye and thank you to Dr Lisa Coussens, AACR President for 2022-2023, Dr Philip… Read More

#Exclusive Content #Opinion

Biotechnology
#Biotechnology #Comment #Events #Genomics #LSX World Congress

Comment: LSX World Congress 2023 

The LSX World Congress 2023 took place at the Business Design Centre in London, UK in May 2023. DDW’s Megan Thomas comments on the event.   New approaches to partnering   In this event in the Biotech track, Clive Cookson, Science Editor at the Financial Times, interviewed… Read More

#Exclusive Content #Opinion

#Advanced Therapies #Cell and gene therapy #Cell therapy #Gene therapy

Under the microscope: Zoning in on the CGT sector

Listen to this article on the DDW Podcast: IB Communications’ CEO Michelle Boxall explains why there are two sides to the cell and gene therapy coin. Charles Dickens’ quote, “It was the best of times, it was the worst of times”, aptly describes the complexity surrounding CGT… Read More

#Exclusive Content #Opinion